Phathom Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PHAT and other ETFs, options, and stocks.

About PHAT

Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ. 

CEO
Steven L. Basta
CEOSteven L. Basta
Employees
427
Employees427
Headquarters
Florham Park, New Jersey
HeadquartersFlorham Park, New Jersey
Founded
2018
Founded2018
Employees
427
Employees427

PHAT Key Statistics

Market cap
279.24M
Market cap279.24M
Price-Earnings ratio
-0.75
Price-Earnings ratio-0.75
Dividend yield
—
Dividend yield—
Average volume
1.08M
Average volume1.08M
High today
$4.40
High today$4.40
Low today
$3.98
Low today$3.98
Open price
$4.11
Open price$4.11
Volume
1.04M
Volume1.04M
52 Week high
$19.71
52 Week high$19.71
52 Week low
$3.81
52 Week low$3.81

Analyst ratings

88%

of 8 ratings
Buy
87.5%
Hold
12.5%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.